This protocol is judged by an institutional review board, an independent team that critiques any clinical trials involving humans. If a research requires a Agenda I drug, as soon as the board approves the protocol as ethical, the scientists really have to submit an application for an investigational new drug (IND) amount through the FDA.He claimed